Synergy Green Industries Ltd Q1 FY27 Earnings Analysis

Published 24 May 2026 | Industrial Products | Market Cap: ₹905 Cr

Price

506

Market Cap

₹905 Cr

P/E Ratio

115.4

Revenue Rank

Rank 2

Margin Rank

Rank 1

Earnings Summary

- FY27 revenue guidance: Approximately ₹500 crores, with potential upside to ₹530-550 crores depending on capacity ramp-up and market conditions. - FY27 revenue guidance is approximately ₹500 crores, with potential upside to ₹530-550 crores based on strong order books and new customer additions.

📊 Revenue & Sales Performance

Rank 2

- FY27 revenue guidance: Approximately ₹500 crores, with potential upside to ₹530-550 crores depending on capacity ramp-up and market conditions. - Projected CAGR growth: Around 15-20% over the coming years. - FY27 expected sales volume: Around 8,500–9,500 tons in some quarters, with current quarter production approx. 6,400 tons. - Capacity utilization expected to ramp from current levels to 80-90% by mid-FY27. - Expansion plans: Land acquisition targeted within FY27 to support capacity additions expected from FY28 onwards, with new capacity commissioning in Q2 FY29. - 10-15% volume growth expected next year due to stabilized existing operations and new customer onboarding. - Export revenues stable, contributing 25-30% of revenue. - New product development and diversification expected to enhance revenue streams. - Some caution on commodity price effects, but margin expansion of 300+ basis points expected with growth.

📈 Profitability & Margins

Rank 1

- FY27 revenue guidance is approximately ₹500 crores, with potential upside to ₹530-550 crores based on strong order books and new customer additions. - Projected revenue growth of about 33% in FY27 driven by expanded capacity and new customer developments. - Margin expansion expected by over 300 basis points in FY27, aided by higher revenues covering overheads and improved efficiencies. - Capacity utilization is expected to cross 80-90% in coming quarters, supporting growth without immediate large capex. - Capex for greenfield expansion is planned around FY28 with estimated costs between ₹500-600 crores, timing aligned with expected growth trajectory. - EBITDA/PBDIT margins, currently around 13.1% in FY26, are forecasted to improve significantly due to operational ramp-up and capacity utilization. - EPS growth is implicitly expected alongside revenue and margin expansion but specific EPS figures were not disclosed.

🏗️ Capital Expenditure Plans

Yes

- Current year FY26 capex of approximately ₹250 crores spent on foundry expansion, machining, and initial new plant land acquisition planning. - Current ₹250 crores capex funded through a mix of internal accruals, debt, and partial equity (debt-equity ratio around 1:1 to 1.2). - FY27 capex to be nominal with minor balancing or small investments; major capex deferred to FY28 and onwards. - Land acquisition (~15-16 acres near existing plant) targeted in FY27, costing around ₹25 crores, funded through internal accruals (not debt). - New greenfield project estimated earlier at ₹500-600 crores (including 50% in-house machining and captive renewables), but cost assessment awaited due to forex fluctuations; clarity expected by Q2/Q3 FY27. - Expansion timeline: decision ideally by Q3 FY27, with ~15 months to commission capacity, aiming for ramp-up in FY29. - Strategic focus on optimizing existing capacity (possible 10-20% stretch) and broadening client base before major expansion.

💰 Fundraising & Capital Structure

Yes

- For the current capex of ₹250 crores, funding is through a mix of internal accruals, equity, and debt, targeting a roughly 1:1 to 1.2 distribution between debt and equity (Page 14). - For FY27, only nominal capex is expected; major capex planned for FY28 onwards, so no significant fundraising this year (Page 14). - Equity or fundraise plans are targeted between Q4 FY27 and Q1/Q2 FY28, aligned with the next phase of capex (Page 19). - Land acquisition (~15-16 acres) costing around ₹25 crores will be funded through internal accruals, not debt (Page 10). - Current debt stands around ₹165-180 crores, expected to reduce to below ₹100 crores (70-80 crores) by next year, maintaining a comfortable debt-to-equity ratio below 1 (Page 10). - Overall, major fundraising (debt/equity) anticipated closer to FY28 with capex requirements; no urgent fundraising expected before then.

📋 Order Book & Pipeline

Yes

- The company has a robust order book with good visibility for FY28, with no major concerns about order availability. - Current rough revenue split guidance is roughly 45% domestic and 55% export. - The order book is estimated around 530 crores, with potential to go up to 700 crores. - Capacity constraints, not order availability, represent the key challenge for growth. - The company has added many new customers and has confirmations from a majority of OEMs. - Order intake is ongoing but there is some internal debate about consolidating orders to focus on high-value, high-volume business. - The company is confident in meeting its order commitments and executing the order book effectively without major issues.

Key Metrics

Revenue

Rank 2

Margin

Rank 1

Capex

Yes

Fundraise

Yes

Order Book

Yes

Frequently Asked Questions

What were Synergy Green Industries Ltd Q1 FY27 results?

- FY27 revenue guidance: Approximately ₹500 crores, with potential upside to ₹530-550 crores depending on capacity ramp-up and market conditions. - FY27 revenue guidance is approximately ₹500 crores, with potential upside to ₹530-550 crores based on strong order books and new customer additions.

What is Synergy Green Industries Ltd share price analysis?

Synergy Green Industries Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 115.4 with a market cap of ₹905. Investors should review the full earnings analysis for detailed insights.

Is Synergy Green Industries Ltd planning capital expenditure?

- Current year FY26 capex of approximately ₹250 crores spent on foundry expansion, machining, and initial new plant land acquisition planning.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.